Skip to main content
UniHealth

Doctor search

Arati Jairam-Thodla, NP

Nurse Practitioner · Stanford

NPI 1649482845

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
20 years
Graduated 2006

On the public record

  • 2 Medical Board actions on record

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Arati Jairam-Thodla’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A22707 · Current

Licensed to practise in California · since 1967 · expires 2027-06-30 · University of California, Los Angeles School of Medicine.

Matched on the licence number without its letter prefix; check the name before relying on it.

Public record actions

Actions the Medical Board of California publishes for this licence
2002-06-03Action in another state or by a federal agencyDisciplineSurrender of license. · New york state board of medicine
1972-07-01Board disciplineDisciplineRevoked. · 02 1971200881

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$22,045

Medicare paid this office $22,045 for 109 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)37$8,016$101
Long return visit (40+ min)24$5,981$136
Return visit (30+ min)59$4,383$60
Long return visit (40+ min)11$1,149$104
Short return visit (20+ min)11$556$46

Who their Medicare patients are

109 Original Medicare patients in 2024. Average age 73 · Women 100% · Also on Medicaid 27% · Health risk score 1.80. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 69% · Cancer 57% · Diabetes 26% · Chronic kidney disease 21% · Depression 21% · Coronary heart disease 15%.

The office billed $123,796, Medicare allowed $30,068 and paid $22,045; for 250 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024109250731.80$123,796$22,045
2023106295731.73$138,093$23,434
2022100254731.95$98,012$16,309
202174251732.08$103,718$16,937
202074254712.21$84,858$13,234
201983245701.86$26,122$14,204
2018101219711.88$20,162$10,754
201795195711.77$23,758$9,390
201683178701.87$25,511$8,092
2015104205711.73$37,203$11,386
20146191692.22$17,116$4,591
20135172701.60$13,522$4,040

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)45$10,662$111
Return visit (30+ min)83$10,520$69
Short return visit (20+ min)13$415$32

2022: 3 services

Original Medicare services billed in 2022
Return visit (30+ min)63$9,207$68
Short return visit (20+ min)62$4,539$49
Long return visit (40+ min)14$2,169$114

2021: 2 services

Original Medicare services billed in 2021
Return visit (30+ min)60$12,697$75
Short return visit (20+ min)32$2,364$41

2020: 3 services

Original Medicare services billed in 2020
Return visit (30+ min)57$8,017$56
Short return visit (20+ min)35$2,685$41
Return visit (30+ min)15$1,481$62

2019: 3 services

Original Medicare services billed in 2019
Return visit (30+ min)68$11,602$59
Long return visit (40+ min)14$1,373$81
Short return visit (20+ min)18$632$29

2018: 3 services

Original Medicare services billed in 2018
Return visit (30+ min)65$7,247$52
Short return visit (20+ min)43$1,549$30
Long return visit (40+ min)11$1,526$80

2017: 3 services

Original Medicare services billed in 2017
Return visit (30+ min)57$6,416$58
Short return visit (20+ min)47$2,306$35
Short return visit11$212$19

2016: 2 services

Original Medicare services billed in 2016
Return visit (30+ min)48$4,545$53
Short return visit (20+ min)44$2,750$38

2015: 3 services

Original Medicare services billed in 2015
Return visit (30+ min)73$8,623$56
Long return visit (40+ min)14$1,266$84
Short return visit (20+ min)26$1,005$39

2014: 1 service

Original Medicare services billed in 2014
Return visit (30+ min)57$4,209$51

2013: 1 service

Original Medicare services billed in 2013
Return visit (30+ min)45$3,623$57

Drugs they prescribed that Part D paid

$1,153,878

Pharmacies billed $1,153,878 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 8% of their Part D prescriptions (40 of 485) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

342 generic and 143 brand-name prescriptions · $1,153,878 in drug cost · 11 antibiotic prescriptions · 12 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lynparza50$586,468$11,729
Lenvima14$327,340$23,381
Eliquis33$19,209$582
Gabapentin26$589$23
Olanzapine15$509$34
See all 15 drugs
Every Part D drug this clinician prescribed
Lynparza50$586,468$11,729
Lenvima14$327,340$23,381
Eliquis33$19,209$582
Gabapentin26$589$23
Olanzapine15$509$34
Ondansetron63$320$5
Prochlorperazine Maleate20$224$11
Letrozole12$221$18
Hydrocodone-Acetaminophen18$202$11
Oxycodone14$164$12
Trazodone11$151$14
Pantoprazole13$126$10
Lorazepam16$69$4
Metoclopramide11$37$3
Atorvastatin11$4$0

Year by year

Part D prescribing by year
2024485718% (40)29%$1,153,878
2023505847% (33)25%$956,549
2022361777% (25)23%$572,201
2021339777% (24)38%$866,954
2020349667% (25)32%$965,374
20193017610% (31)24%$568,296
20182567418% (45)19%$296,648
20173467217% (57)16%$271,828
20163027619% (57)14%$146,535
20152917027% (78)17%$130,773
20142496816% (39)None$29,820
20132456119% (47)13%$59,291

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 15 drugs

Part D drugs prescribed in 2023
Lynparza36$414,090$11,503
Lenvima14$356,673$25,477
Eliquis36$21,200$589
Maxidex11$1,024$93
Gabapentin15$986$66
Ondansetron65$645$10
Letrozole16$491$31
Prochlorperazine Maleate30$390$13
Pantoprazole24$179$7
Oxycodone17$173$10
Trazodone12$154$13
Metoclopramide13$93$7
Oxybutynin Chloride11$72$7
Hydrocodone-Acetaminophen11$64$6
Prednisone17$28$2

2022: 8 drugs

Part D drugs prescribed in 2022
Lynparza42$392,710$9,350
Zejula12$155,780$12,982
Eliquis15$10,048$670
Letrozole25$598$24
Ondansetron45$417$9
Prochlorperazine Maleate29$336$12
Hydrocodone-Acetaminophen14$213$15
Lorazepam14$45$3

2021: 7 drugs

Part D drugs prescribed in 2021
Lynparza53$562,002$10,604
Zejula20$172,479$8,624
Eliquis19$11,043$581
Ondansetron31$526$17
Letrozole16$455$28
Prochlorperazine Maleate18$268$15
Lorazepam15$44$3

2020: 11 drugs

Part D drugs prescribed in 2020
Lynparza47$620,501$13,202
Zejula19$153,664$8,088
Xarelto12$6,891$574
Ondansetron28$985$35
Prochlorperazine Maleate17$176$10
Dexamethasone14$137$10
Lactulose14$125$9
Metoclopramide12$40$3
Lorazepam15$34$2
Tramadol13$27$2
Prednisone11$24$2

2019: 8 drugs

Part D drugs prescribed in 2019
Lynparza20$271,339$13,567
Zejula17$178,799$10,518
Megestrol Acetate11$296$27
Ondansetron35$292$8
Prochlorperazine Maleate16$176$11
Metoclopramide27$133$5
Lorazepam15$105$7
Oxycodone13$84$6

2018: 7 drugs

Part D drugs prescribed in 2018
Lynparza20$199,698$9,985
Letrozole15$231$15
Ondansetron19$184$10
Oxycodone14$161$12
Lorazepam23$95$4
Tramadol11$40$4
Metoclopramide12$31$3

2017: 8 drugs

Part D drugs prescribed in 2017
Lynparza13$113,159$8,705
Ondansetron29$501$17
Letrozole16$485$30
Gabapentin19$464$24
Oxycodone14$275$20
Lorazepam48$211$4
Metoclopramide32$112$4
Tramadol15$59$4

2016: 5 drugs

Part D drugs prescribed in 2016
Oxycodone26$489$19
Ondansetron38$375$10
Lorazepam38$300$8
Letrozole25$219$9
Metoclopramide23$105$5

2015: 6 drugs

Part D drugs prescribed in 2015
Oxycodone39$1,035$27
Tamoxifen Citrate14$424$30
Hydrocodone-Acetaminophen17$326$19
Ondansetron21$312$15
Lorazepam26$139$5
Metoclopramide17$67$4

2014: 8 drugs

Part D drugs prescribed in 2014
Enoxaparin14$12,109$865
Anastrozole14$1,004$72
Megestrol Acetate15$837$56
Letrozole20$793$40
Oxycodone15$338$23
Ondansetron14$205$15
Lorazepam21$97$5
Metoclopramide15$84$6

2013: 6 drugs

Part D drugs prescribed in 2013
Letrozole14$581$41
Gabapentin21$375$18
Oxycodone16$323$20
Lorazepam24$143$6
Hydrocodone-Acetaminophen12$126$10
Zolpidem11$54$5

Money from drug and device companies

$17 in 2025

Industry payments by year
202511None$17
202411None$27
202345$1,150$1,399
202235None$113

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPEnhertu$17
1 payment
  • Meals for Enhertu · 2025-12-17 · $17
See the published payment
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-17Enhertu$17
See earlier years (2024, 2023, 2022)

2024: $27

Payments by company in 2024
Merck Sharp & DohmeLynparza$27
1 payment
  • Meals for Lynparza · 2024-01-31 · $27

2023: $1,399

Payments by company in 2023
AstraZeneca Pharmaceuticals LPLynparza$1,274
2 payments
  • Paid to speak or teach for Lynparza · 2023-05-11 · $1,150
  • Meals for Lynparza · 2023-04-27 · $124
Myriad Genetic LaboratoriesPrecisetumor$68
1 payment
  • Meals for Precisetumor · 2023-03-02 · $68
Merck Sharp & DohmeKeytruda$33
1 payment
  • Meals for Keytruda · 2023-10-18 · $33
GlaxoSmithKlineZejula$24
1 payment
  • Meals for Zejula · 2023-10-11 · $24

2022: $113

Payments by company in 2022
GlaxoSmithKlineZejula$50
2 payments
  • Meals for Zejula · 2022-05-04 · $23
  • Meals for Zejula · 2022-02-09 · $27
Myriad Genetic LaboratoriesPrecisetumor$45
2 payments
  • Meals for Precisetumor · 2022-10-17 · $30
  • Meals for Precisetumor · 2022-10-13 · $16
AstraZeneca Pharmaceuticals LPEnhertu$17
1 payment
  • Meals for Enhertu · 2022-04-06 · $17

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1649482845
Licence
CA 22707, CA 834329California A22707: Current · expires 2027-06-30
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 163WX0200X (163WX0200X); Federal specialty code 363LX0001X (363LX0001X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-05-03
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.